LIC MF HEALTHCARE FUND

LIC Mutual FundThematicPortfolio as of 31 July 2026

LIC MF HEALTHCARE FUND holds 24 instruments (96.91% equity), led by Sun Pharmaceutical Industries Limited (10.69%), Divi's Laboratories Limited (9.47%) and Torrent Pharmaceuticals Limited (6.89%), as of its 31 July 2026 SEBI-mandated monthly disclosure.

Holdings
24
Equity Allocation
96.91%
AMC
LIC Mutual Fund
Category
Thematic

This page shows the complete disclosed portfolio of LIC MF HEALTHCARE FUND, managed by LIC Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 24 instruments with an equity allocation of 96.91%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.

Portfolio Analysis

LIC MF HEALTHCARE FUND's top 10 holdings account for 63.19% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 91.71% of net assets, spread across 2 sectors in total. Since its 30 June 2026 disclosure, the fund added 1 new position and exited 2 positions, with Divi's Laboratories Limited seeing the largest move (+2.3pp to 9.47%).

Top 10 Equity Holdings

What Changed: June 2026 → July 2026

Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

1 new entry2 exits7 increased10 reduced

Biggest Weight Increases

StockWeightChange
Divi's Laboratories Limited7.17% → 9.47%▲ +2.3
Aster DM Healthcare Limited3.18% → 4.67%▲ +1.49
Max Healthcare Institute Limited2.05% → 2.84%▲ +0.79
Mankind Pharma Limited2.36% → 3.12%▲ +0.76
Torrent Pharmaceuticals Limited6.55% → 6.89%▲ +0.34
Artemis Medicare Services Limited2.68% → 2.86%▲ +0.18
Sun Pharmaceutical Industries Limited10.55% → 10.69%▲ +0.14

Biggest Weight Reductions

StockWeightChange
Navin Fluorine International Limited5.58% → 5.2%▼ -0.38
Fortis Healthcare Limited4.45% → 4.16%▼ -0.29
Aurobindo Pharma Limited5.3% → 5.02%▼ -0.28
Zydus Lifesciences Limited5.11% → 4.9%▼ -0.21
Gland Pharma Limited3.79% → 3.6%▼ -0.19
Onesource Specialty Pharma Limited2.67% → 2.49%▼ -0.18
Neuland Laboratories Limited5.74% → 5.57%▼ -0.17
Apollo Hospitals Enterprise Limited6.77% → 6.62%▼ -0.15
Glenmark Pharmaceuticals Limited2.86% → 2.74%▼ -0.12
Dr. Agarwal's Health Care Limited2.05% → 1.94%▼ -0.11

Top Holdings — Weight Trend

% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).

Feb: 11.09%, Mar: 11.77%, Apr: 11.22%, May: 10.61%, Jun: 10.55%, Jul: 10.69%
10.69%
Feb: 4.81%, Mar: 4.68%, Apr: 4.74%, May: 7.56%, Jun: 7.17%, Jul: 9.47%
9.47%
Feb: 6.93%, Mar: 7.08%, Apr: 6.5%, May: 6.51%, Jun: 6.55%, Jul: 6.89%
6.89%
Feb: 6.87%, Mar: 6.84%, Apr: 6.52%, May: 6.63%, Jun: 6.77%, Jul: 6.62%
6.62%
Feb: 4.04%, Mar: 3.97%, Apr: 4.59%, May: 5.49%, Jun: 5.74%, Jul: 5.57%
5.57%

Full Portfolio (24 holdings)

#HoldingSector% to NAV
1Sun Pharmaceutical Industries LimitedHealthcare10.69%
2Divi's Laboratories LimitedHealthcare9.47%
3Torrent Pharmaceuticals LimitedHealthcare6.89%
4Apollo Hospitals Enterprise LimitedHealthcare6.62%
5Neuland Laboratories LimitedHealthcare5.57%
6Navin Fluorine International LimitedMaterials5.2%
7Aurobindo Pharma LimitedHealthcare5.02%
8Zydus Lifesciences LimitedHealthcare4.9%
9Aster DM Healthcare LimitedHealthcare4.67%
10Fortis Healthcare LimitedHealthcare4.16%
11Gland Pharma LimitedHealthcare3.6%
12Global Health LimitedHealthcare3.2%
13TREPStreps3.17%
14Mankind Pharma LimitedHealthcare3.12%
15IPCA Laboratories LimitedHealthcare2.97%
16Artemis Medicare Services LimitedHealthcare2.86%
17Max Healthcare Institute LimitedHealthcare2.84%
18Metropolis Healthcare LimitedHealthcare2.82%
19Biocon LimitedHealthcare2.77%
20Glenmark Pharmaceuticals LimitedHealthcare2.74%
21Onesource Specialty Pharma LimitedHealthcare2.49%
22Cohance Lifesciences LimitedHealthcare2.37%
23Dr. Agarwal's Health Care LimitedHealthcare1.94%
24Net Receivables / (Payables)other-0.1%

Frequently Asked Questions

Yes. As of its 31 July 2026 disclosure, Sun Pharmaceutical Industries Limited is 10.69% of LIC MF HEALTHCARE FUND's net assets — its number 1 holding.
Yes. As of its 31 July 2026 disclosure, Divi's Laboratories Limited is 9.47% of LIC MF HEALTHCARE FUND's net assets — its number 2 holding.
Yes. As of its 31 July 2026 disclosure, Torrent Pharmaceuticals Limited is 6.89% of LIC MF HEALTHCARE FUND's net assets — its number 3 holding.
Yes. As of its 31 July 2026 disclosure, Apollo Hospitals Enterprise Limited is 6.62% of LIC MF HEALTHCARE FUND's net assets — its number 4 holding.
Yes. As of its 31 July 2026 disclosure, Neuland Laboratories Limited is 5.57% of LIC MF HEALTHCARE FUND's net assets — its number 5 holding.

New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.

Source: LIC Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.